SELF NANO EMULSIFYING DRUG DELIVERY SYSTEM OF RAMIPRIL: FORMULATION AND IN VITRO EVALUATION
Objective: The primary goal of the present work was to formulate and evaluate self-nano emulsifying drug delivery systems (SNEDDS) of ramipril in order to improve the solubility of this highly lipophilic antihypertensive drug.
Methods: SNEDDS are generally liquid form preparations obtained by homogeneously mixing drug substance with oils, surfactants and co-surfactants using cyclomixer. Based on solubility studies Capmul PG8 NF, Gelucire 44/14 and Transcutol P were selected as oil, surfactant and co-surfactant respectively in order to prepare SNEDDS. Nine different SNEDDS formulations were prepared and subjected to various evaluation tests in order to obtain optimized SNEDDS formulation.
Results: The SNEDDS formulations with 16.5-24.75 % of oil, 24.75-68.75 % of surfactant and 12.375-41.25 % of co-surfactant formed thermodynamically stable emulsion with droplet size ranging from 22.6-188.8 nm. Finally, out of 9 different SNEDDS formulations, SN9 formulation was optimized containing 16.5 % of oil, 68.75 % of surfactant and 13.75 % of co-surfactant as it formed a thermodynamically stable emulsion with least globule size (22.6 nm) and without any drug precipitation or phase separation.
Conclusion: Finally, stable, optimized SNEDDS formulation of ramipril was successfully prepared that showed significant improvement in the rate of dissolution of ramipril.
Keywords: Self nano emulsifying drug delivery system (SNEDDS), Ramipril, Emulsification time, Ternary phase diagram, Simulated Gastric Fluid (SGF).
2. Kommura TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 2001;212:233â€“46.
3. Holm R, Porter CJ, Edwards GA, Mullertz A, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self micro emulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci 2003;20:91â€“7.
4. Kapsi SG, Ayres JW. Processing factors in the development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int J Pharm 2001;229:193â€“203.
5. Veiga F, Fernandes C, Maincent P. Influence of the preparation method on the physicochemical properties of tolbutamide/ cyclodextrin binary systems. Drug Dev Ind Pharm 2001;27:523â€“32.
6. Rogers TL, Hu J, Yu Z, Johnston KP, Williams III RO. A novel particle engineering technology: spray freezing into liquid. Int J Pharm 2002;242:93â€“100.
7. Popescu C, Manda P, Juluri A, Janga K, Cidda M, Murthy SN. Enhanced dissolution efficiency of solid zaleplon dispersions via modified Î²-cyclodextrin molecular inclusion complexes. J Pharm Pharm Sci 2015;1:12-21.
8. Lian Dong H, Xing T, Fu De C. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 2004;56:1527-35.
9. Zhang Z, Bu H, Gao Z, Huang Y, Gao F, Li Y. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int J Pharm 2010;394:147-53.
10. Prego C, Fabre M, Torres D, Alonso MJ. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res 2006;23:549-56.
11. Nassar T, Rom A, Nyska A, Benita S. Novel doubled coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug. J Controlled Release 2009;133:77-84.
12. De Smidt PC, Campanero MA, Troconiz IF. Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int J Pharm 2004;270:109-18.
13. Gao F, Zhang Z, Bu H, Huang Y, Gao Z, Shen J, et al. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism. J Controlled Release 2011;149:168-74.
14. Zheng JY, Fulu MY. The decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion. Int J Pharm 2006;307:209-15.
15. Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, et al. Docetaxel microemulsion for enhanced oral bioavailability: preparation and pertaining in vitro and in vivo evaluation. J Controlled Release 2009;140:86-94.
16. Li H, An JH, Park JS, Han K. Multivesicular liposomes for oral delivery of recombinant human epidermal growth factor. Arch Pharm Res 2005;28:988-94.
17. Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery. Pharmazie 2006; 61:106-11.
18. Gurrapu A, Jukanti R, Bobbala SR, Kanuganti S, Jeevana JB. Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol 2012;23:583-90.
19. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. Quality by design: understanding the product variability of a self nano emulsified drug delivery system of cyclosporine A. J Pharm Sci 2007;96:2409â€“23.
20. Robert GS. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201â€“30.
21. Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self emulsifying formulations of halofantrine. Int J Pharm 1998;167:155-64.
22. Amit AK, Vandana BP. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS Pharm Sci Technol 2008;9:191-6.
23. Sheikh S, Faiyaz S, Sushma T, Farhan JA, Roop KK, Mushir A. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227â€“43.
24. Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of oridonin. Int J Pharm 2008;355:269â€“76.
25. Yosra SRE, Magda AE, Ossama YA. Self-nano emulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm 2009;380:133â€“41.
26. Ashok RP, Pradeep RV. Preparation and in vivo evaluation of SMEDDS (self-micro emulsifying drug delivery system) containing fenoï¬brate. AAPS Pharm Sci Technol 2007;9: E344-52.
27. Hauss DJ, Fogal SE, Ficorlilli JV, Price CA, Roy T, Jayaraj AA, et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 1998;87:164-9.
28. Serajuddin AT, Sheen PC, Mufson D, Bernstein DF, Augustine MA. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J Pharm Sci 1988;77:414-7.
29. Itoh K, Tozuka Y, Oguchi T, Yamamoto K. Improvement of physicochemical properties of N-4472 part I formulation design by using the self-micro emulsifying system. Int J Pharm 2002;238:153â€“60.
30. Rajan BM, Nirav SS. A review: self-emulsifying drug delivery system. Int J Pharm Pharm Sci 2011;3 Suppl 2:23-8.
31. Jung SL, Marc A, Ebel P, Raymond M, Wim EH, Jan F. Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes. J Controlled Release 2011;155:282-8.
32. Amit AK, Vandana BP. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS Pharm Sci Technol 2008;9:191-6.